In 2000, the FDA regulated the use of reprocessed single-use devices in the U.S. to address concerns about patient safety. Reprocessing has environmental benefits, reducing CO2 emissions and carbon footprints. As the U.S. falls behind, other countries like the UK and France are implementing sustainability efforts in healthcare, particularly in electrophysiology (EP). Reprocessing has potential to reduce supply tensions, limit environmental impact, and lower procedural costs. The French Society of Cardiology has proposed reprocessing as a solution. Manufacturers, medical societies, and hospitals need to take action to create meaningful change. The U.S. needs to build on its early leadership in EP sustainability efforts to avoid falling behind other countries.
Source link
Is Europe About to Overtake the U.S.’s Leadership Position in Healthcare Sustainability via Reprocessing?
